The rare hematologic malignancy known as chronic myelomonocytic leukemia was the subject of a recent study that compared outcomes from patients treated at academic centers versus nonacademic centers.
Chronic myelomonocytic leukemia (CMML) is a less common type of chronic leukemia that causes too many monocyte cells to build up in the blood. It often causes an enlarged spleen, so people with ...
its novel CCR2-CyTAC™ (Cytotoxicity Targeting Chimera), for the treatment of chronic myelomonocytic leukemia (CMML) and acute myeloid leukemia (AML). Results were presented over the weekend in ...